Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
about
Venous thromboembolic diseaseRenal replacement therapy in acute kidney injury: controversy and consensusDirect thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.Heparin-dependent platelet factor 4 antibodies and the impact of renal function on clinical outcomes: a retrospective study in hospitalized patients.Current concepts review: heparin-induced thrombocytopenia.Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.Heparin-induced thrombocytopenia: overview and treatment.Thrombocytopenia following percutaneous coronary intervention.Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?Correlation of bivalirudin dose with creatinine clearance during treatment of heparin-induced thrombocytopenia.Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia.Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.Hats Off to HIT: A Case Report.Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.Successful use of a bivalirudin treatment protocol to prevent extracorporeal thrombosis in ambulatory hemodialysis patients with heparin-induced thrombocytopenia.Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.Dosing nomograms: silos on a slope.Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.Prophylaxis and treatment of venous thromboembolism in the critically ill.Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy.Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.Bivalirudin Medication Use Evaluation and Cost Savings Initiative.
P2860
Q24631121-BC4159CA-054E-41C6-B3C7-CCEB70B543D5Q26998864-5D4ECB9B-D455-4467-93F4-22AF323D6AE0Q33373700-E232ADF4-D35B-4120-8F0B-E3926AA33AD3Q33374658-DFC0F6E3-8DCE-4A71-AE41-B38EE189D514Q33380931-791C9120-DFB9-478D-9364-AEFE8AB00B82Q33381429-F2A1F1BF-AF70-4945-A95C-CDE934AF8DBBQ33382108-E5142E87-FC85-4027-AB3B-E3BC6046232CQ33385297-69973CEA-8A25-4718-9F1A-3700EAA71204Q33386197-D4EB6FAB-0C9E-4697-943B-9FFBC9D9FA7DQ33387648-913012EA-D9CF-46B3-A36A-2391045CDF95Q33393015-DF230052-E3AC-411E-B850-0E20437EED6FQ33394188-5F5BCF9D-9EF6-4C6B-AACE-DDCA21C39781Q33394199-7DEFCB61-0929-4D1E-AAB1-DD06349F37A5Q33394988-FC79649D-6E73-4B75-A9CA-FD742AE724F9Q33397244-46BB83D5-06B2-4F7A-8477-2219DB426BF5Q33399307-C3548F9A-80F2-4514-A6F1-7196310B299DQ33400101-2F475E6E-8EEF-4DFD-8DA8-D0EBCBF59863Q33402428-39EF5453-0EC7-40F0-A800-710D8EA2E1FEQ33409277-14B52626-37C8-42FA-95E7-8C7611D8039FQ33411642-10A08474-ABC6-41BE-881C-7ED4B7268B67Q33427036-A5014D37-B8B8-43F6-A25A-9AE23CB406B2Q33442600-A440BFD2-1144-452F-9F10-A540C9491F04Q37363635-D1925896-AB58-4398-9884-48094153098FQ38107945-F89D5F8E-3DB3-4C59-AC06-95670B3040C3Q38130269-9C4F2124-F9A7-44A6-BA34-5126408FAEEFQ38463548-BA35E053-AAD6-4A55-B647-F710BCCCE45BQ42848627-D58AB3FE-1E9E-4258-AF74-4773A18305DDQ49587021-6AD4B98D-15E6-46A6-A0B9-267CD770E2DB
P2860
Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@ast
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@en
type
label
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@ast
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@en
prefLabel
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@ast
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@en
P2860
P356
P1433
P1476
Evaluation of bivalirudin trea ...... atic and/or renal dysfunction.
@en
P2093
Douglas N Fish
P2860
P304
P356
10.1592/PHCO.26.4.452
P407
P577
2006-04-01T00:00:00Z